To determine if downregulation of ACP6 is necessary and sufficient to promote ovarian cancer progression in vitro and in vivo, we investigated the effect of ACP6 knockdown and overexpression with the well-characterized32 wild-type p53 HeyA8 ovarian cancer cell line (Supplementary Fig. S3c,d). The gene discussed is TP53; the disease is ovarian cancer.